Breast Cancer Diagnoses Are Rising Fastest in Women Under 50, New Data Show

Breast cancer is being diagnosed in younger American women at a faster pace than at any point in decades, according to new data cited this week by the American Cancer Society, as the country enters another October awareness campaign aimed partly at that shift. The American Cancer Society projects that 321,910 women in the United States will be diagnosed with invasive breast cancer this year, and the disease's incidence rate among women younger than 50 is now climbing roughly twice as fast as it is among older women.

The trend was laid out in a CBS News report published Wednesday morning, in which oncologist Dr. Eleonora Teplinsky, head of breast and gynecologic medical oncology at Valley-Mount Sinai Comprehensive Cancer Care in Paramus, New Jersey, walked through what is driving the increase, what women can realistically do about it, and why she tells patients that prevention has limits.

The numbers behind the trend

Overall incidence has been rising by about 1% a year in recent years, but the increase is steeper in women under 50, at 1.4% annually — nearly double the broader trend. About one in 10 women diagnosed with breast cancer are younger than 45, and breast cancer remains one of the most common cancers diagnosed in adolescents and young adults under 39. Lifetime risk for an average American woman is about 13%, or roughly one in eight.

The disease does not fall evenly across racial and ethnic groups. The cancer society's data show Black women are more likely to die of breast cancer than women of any other race or ethnicity at every stage of diagnosis, even though their incidence rate is slightly lower than that of white women. White, Asian and Pacific Islander women are more likely than Black, Hispanic, American Indian and Alaska Native women to be diagnosed while the cancer is still in its early, more treatable stages.

How the medical community got here

Researchers have not settled on a single explanation for why diagnoses are climbing fastest in younger women, and Dr. Teplinsky was direct about the limits of that understanding in the CBS News interview. Candidates under discussion include earlier onset of menstruation, women having their first child later in life, diets heavier in ultra-processed foods and added sugar, less physical activity, and possible effects of everyday chemical exposures such as plastics, parabens and phthalates — though she cautioned that the research tying those exposures directly to breast cancer risk is still thin.

Alcohol is the one factor she described in blunter terms. "Number one is eliminate alcohol," she said, calling it a carcinogen directly tied to causing the disease rather than merely a risk factor to manage in moderation. She paired that advice with two more concrete recommendations: roughly 150 minutes of exercise a week, and cutting back on ultra-processed foods and processed meats.

Who is affected, and what screening looks like now

The shift toward younger diagnoses matters for screening decisions that many women make with their doctors in their late 30s and early 40s. The American Cancer Society's current screening guidance gives average-risk women the option to begin annual mammograms at 40, recommends yearly mammograms from 45 to 54, and allows women 55 and older to move to every other year if they remain in good health. Women considered high-risk — because of family history or genetic factors such as BRCA mutations — are generally advised to start annual mammograms and breast MRIs around age 30.

The Centers for Disease Control and Prevention echoes the one-in-ten figure for women diagnosed before 45 and directs women without insurance or with limited income toward its National Breast and Cervical Cancer Early Detection Program, reachable at 800-232-4636, which pays for screening in every state.

Survivors face a separate set of questions once treatment ends, particularly around menopause symptoms that many had treated with hormone therapy before their diagnosis. Dr. Teplinsky told CBS News that low-dose vaginal estrogen — a localized treatment that is not absorbed into the broader bloodstream — can be an option for some breast cancer survivors managing symptoms such as vaginal dryness, though she stressed that it requires an individual conversation with a patient's own oncology team rather than a blanket recommendation.

What people are saying

The core of Dr. Teplinsky's message, as relayed by CBS News, was aimed less at alarm than at recalibrating what patients and families should expect from "doing everything right." She pushed back on the idea that a diagnosis reflects some personal failure of diet, exercise or vigilance.

"You can do all the right things and be diagnosed with breast cancer, and you can do none of the right things and not be diagnosed with breast cancer."

She also reframed when support for patients should begin, arguing that survivorship — the practical and emotional work of living with and after a cancer diagnosis — starts immediately rather than only after treatment ends. "Survivorship starts at the day of diagnosis," she said.

What happens next

October's awareness campaigns will keep the spotlight on screening access and early detection over the next several weeks, with the cancer society and the CDC both pointing women toward conversations with their own doctors about when to start mammograms given family history and other personal risk factors. For researchers, the open question is why the under-50 trend line keeps steepening: identifying which combination of reproductive patterns, diet, inactivity and environmental exposure is actually driving the numbers will shape where prevention research and public health messaging focus next. In the meantime, the guidance from oncologists like Dr. Teplinsky is narrower and more immediate — cut alcohol, move more, eat less processed food, and talk to a doctor about a personal screening timeline — paired with the caveat that none of it guarantees an outcome either way.